
MEI Pharma (Formerly Marshall Edwards)
Innovative oncology therapies targeting unmet medical needs in cancer treatment.
Market cap
$18.7m
Enterprise value
($20m)
Share price
$2.47 MEIP
Authorizing premium user...
Innovative oncology therapies targeting unmet medical needs in cancer treatment.